Publications by authors named "Andrew W Michell"

Claim this Profile
R
Remyelination in humans due to a retinoid-X receptor agonist is age-dependent.
Christopher E McMurran, Trisha Mukherjee, J William L Brown, Andrew W Michell, Declan T Chard

Ann Clin Transl Neurol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study.
J William L Brown, Nick G Cunniffe, Ferran Prados, Baris Kanber, Joanne L Jones, Andrew W Michell

Lancet Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility Trial of Treatment of Ulnar Neuropathy at the Elbow Using a Specifically Designed Splint.
Andrew W Michell, Hewa G R Sesath

J Clin Rheumatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in EEG: home video telemetry, high frequency oscillations and electrical source imaging.
Anjla C Patel, Rachel C Thornton, Tejal N Mitchell, Andrew W Michell

J Neurol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Errata: Hemodynamic response to burst-suppressed and discontinuous electroencephalography activity in infants with hypoxic ischemic encephalopathy.
Maria Chalia, Chuen Wai Lee, Laura A Dempsey, Andrea D Edwards, Harsimrat Singh, Andrew W Michell

Neurophotonics· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic response to burst-suppressed and discontinuous electroencephalography activity in infants with hypoxic ischemic encephalopathy.
Maria Chalia, Chuen Wai Lee, Laura A Dempsey, Andrea D Edwards, Harsimrat Singh, Andrew W Michell

Neurophotonics· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Examination Versus Electrodiagnostic Assessment of Severity of Median Nerve Pathology in Carpal Tunnel Syndrome.
Paul W A Masson, Andrew W Michell

J Clin Rheumatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.
J William L Brown, Peter J Martin, John W Thorpe, Andrew W Michell, Alasdair J Coles

J Neuroimmunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Techniques and applications of EMG: measuring motor units from structure to function.
Rachel C Thornton, Andrew W Michell

J Neurol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Peter Connick, Madhan Kolappan, Charles Crawley, Daniel J Webber, Rickie Patani, Andrew W Michell

Lancet Neurol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
Sarosh R Irani, Andrew W Michell, Bethan Lang, Philippa Pettingill, Patrick Waters

Ann Neurol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's disease--the continuing search for biomarkers.
David P Breen, Andrew W Michell, Roger A Barker

Clin Chem Lab Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments.
Peter Connick, Madhan Kolappan, Rickie Patani, Michael A Scott, Charles Crawley, Andrew W Michell

Trials· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"The eyes have it". Saccadometry and Parkinson's disease.
Roger A Barker, Andrew W Michell

Exp Neurol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in Huntington's and Parkinson's Disease.
Gráinne C O'Keeffe, Andrew W Michell, Roger A Barker

Ann N Y Acad Sci· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualising disease progression on multiple variables with vector plots and path plots.
Stanley E Lazic, Sarah L Mason, Andrew W Michell, Roger A Barker

BMC Med Res Methodol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurogenesis in diseases of the central nervous system.
Wendy Phillips, Andrew W Michell, Roger A Barker

Stem Cells Dev· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles.
Benjamin R Underwood, David Broadhurst, Warwick B Dunn, David I Ellis, Andrew W Michell

Brain· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lewy bodies in Parkinson's disease: protectors or perpetrators?
Timothy P Harrower, Andrew W Michell, Roger A Barker

Exp Neurol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease.
Andrew W Michell, Leila M Luheshi, Roger A Barker

Neurosci Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis